Centrexion Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Boston MA United States (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2013
NCT00667654
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Centrexion Therapeutics | Centrexion Therapeutics Corp